Reducing Energy: Eliminating The Cold Chain

How Windgap Medical’s lyophilized autoinjector platforms cut CO2 emissions and costs

Global healthcare systems account for over 4% of CO2 emissions worldwide—with the number climbing to almost 10% for industrialized nations. A significant component of these emissions is due to cold chain storage, which requires an energy-intensive approach to controlling temperature conditions from manufacturing to point of care.

“THE GREATEST HEALTH OPPORTUNITY OF THE 21st CENTURY”

In their 11th edition of the Biopharma Cold Chain Sourcebook, Pharmaceutical Commerce estimates that up to 30% of biologics' total costs come from cold chain logistics, which also carry a significant environmental footprint. With rising fuel costs and the Lancet Commission stating that “tackling climate change could be the greatest health opportunity of the 21st century,” many pharmaceutical companies have set ambitious environmental, social, and governance targets to do their part.

To achieve those aspirations, and improve the reach of their innovative, life-sustaining therapies, leading pharmaceutical companies are seeking advanced drug delivery systems that can reduce or eliminate the need for cold chain logistics.

THE SOLUTION IS NOT A SOLUTION.

Many biologics, including GLP-1s and antibodies, require cold chain storage when formulated as liquids. One solution? Eliminate the (liquid) solution—until the point and moment of administration.

Windgap Medical’s lyophilized drug delivery platforms provide a sustainable alternative by enabling room temperature stability and reducing or removing the need for cold storage. These wet-dry autoinjectors significantly reduce energy consumption throughout the supply chain, lower CO2 emissions, cut costs, and simplify logistics.

Windgap Medical is revolutionizing drug delivery systems with our innovative lyophilized platforms. By focusing on room temperature stability and eliminating the need for cold chain logistics, we are not only cutting down CO2 emissions but also reducing operational costs and simplifying the supply chain. Our commitment to sustainability ensures that we deliver advanced healthcare solutions without compromising the health of our planet.

Find out how Windgap can Inject Sustainability into your complex drug formulation and delivery here.


This post is part of a 5-part series about “Injecting Sustainability” into complex drug delivery. Find the full series here.

Previous
Previous

Injecting Sustainability: The 4th “R”—Responsibility

Next
Next

Reducing Operational Waste: Streamlining Drug Development with Innovative Autoinjectors